Keyphrases
Psoriasis Treatment
100%
Inflammatory Disorders
100%
TNF Inhibitors
100%
Adverse Events
75%
Non-neoplastic
75%
Psoriasis Disease
50%
Non-infectious
50%
Etanercept
50%
Adalimumab
50%
Organ System
25%
Inhibitor Therapy
25%
Psoriasis
25%
Literature Search
25%
Inflammatory Response
25%
Noninflammatory
25%
MEDLINE
25%
Infliximab
25%
Malignancy
25%
Adverse Effects
25%
Search Strategy
25%
Underreported
25%
Medicine and Dentistry
Psoriasis
100%
Inflammatory Disorder
100%
TNF Inhibitor
100%
Adverse Event
75%
Adalimumab
50%
Etanercept
50%
Adverse Effect
25%
Side Effect
25%
Organ Systems
25%
Cancer
25%
Infection
25%
Serositis
25%
Infliximab
25%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Tumor Necrosis Factor Inhibitor
100%
Adverse Event
75%
Etanercept
50%
Adalimumab
50%
Inflammation
25%
Infection
25%
Side Effect
25%
Infliximab
25%